Serum neurofilaments as a potential biomarker of disability and cognitive decline in patients with multiple sclerosis

被引：0
|
作者：
Yanakieva, Magdalina [1 ]
Ovcharova, Emilia [1 ]
Danovska, Maya [1 ]
Marinova-Trifonova, Diana [1 ]
Atanasova, Milena [2 ]
机构：
[1] UMHAT Dr Georgi Stranski Med Univ Pleven, Neurol Clin, Pleven, Bulgaria
[2] Med Univ Pleven, Pleven, Bulgaria
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1546/1103
引用
收藏
页码：980 / 981
页数：2
相关论文
共 50 条
  • [21] Cognitive decline predicts disability progression in relapsing-remitting multiple sclerosis
    Vermersch, Patrick
    Leuse, Delphine
    Cabaret, Maryline
    Outteryck, Olivier
    de Seze, Jerome
    Dujardin, Kathy
    Zephir, Helene
    MULTIPLE SCLEROSIS, 2008, 14 : S266 - S266
  • [22] The Impact of Cognitive Decline on Quality of Life in Multiple Sclerosis Patients
    de Vecino, Maria Cecilia A.
    de Caneda, Marco Aurelio G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 152 - 152
  • [23] Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis
    Motyl, Jiri
    Friedova, Lucie
    Vaneckova, Manuela
    Krasensky, Jan
    Lorincz, Balazs
    Blahova Dusankova, Jana
    Andelova, Michaela
    Fuchs, Tom A.
    Kubala Havrdova, Eva
    Benedict, Ralph H. B.
    Horakova, Dana
    Uher, Tomas
    DIAGNOSTICS, 2021, 11 (03)
  • [24] Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis
    Esmael, Ahmed
    Elsherif, Mohamed
    Abdelsalam, Mohamed
    Sabry, Dalia
    Mamdouh, Mohamed
    Belal, Tamer
    NEUROLOGICAL RESEARCH, 2020, 42 (07) : 564 - 574
  • [25] Validation of microsaccades as a biomarker for disability in multiple sclerosis
    Sheehy, Christy K.
    Shi, Bingyan
    Bensinger, Ethan
    Romeo, Andrew
    Rani, Lakshmisahithi
    Devereux, Michael
    Gelfand, Jeffrey
    Stevenson, Scott B.
    Green, Ari
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [26] No Relation Between Cognitive Impairment, Physical Disability and Serum Biomarkers in a Cohort of Progressive Multiple Sclerosis Patients
    Gajewski, Bartosz
    Karlinska, Iwona
    Domowicz, Malgorzata
    Bednarski, Igor
    Swiderek-Matysiak, Mariola
    Stasiolek, Mariusz
    BIOMOLECULES, 2025, 15 (01)
  • [27] Antibodies against light neurofilaments in multiple sclerosis patients
    Bartos, A.
    Fialova, L.
    Soukupova, J.
    Kukal, J.
    Malbohan, I.
    Pitha, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (02): : 100 - 107
  • [28] Evaluation of serum light chain neurofilaments in Relapsing Multiple Sclerosis patients NEDA-3
    Meca-Lallana, V.
    Aguirre, C.
    Diaz Perez, C.
    Sobrado, M.
    Costa-Frossard, L.
    Vivancos, J.
    Carabajal, E.
    del Rio, B.
    Sainz de la Maza, S.
    Monreal, E.
    Villar Guimerans, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 33 - 33
  • [29] Could high sensitivity ELISA method be an option to determinate serum neurofilaments in patients with multiple sclerosis?
    Revendova, K.
    Kusnierova, P.
    Karasova, K.
    Bunganic, R.
    Hradilek, P.
    Volny, O.
    Bar, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 820 - 821
  • [30] Serum Cathepsin D Is a Potential Biomarker for Alzheimer's Disease Dementia and Cognitive Decline
    Chai, Yuek Ling
    Liang, Nathan Hao Ping
    Chong, Joyce R.
    Venketasubramanian, Narayanaswamy
    Tan, Boon Yeow
    Hilal, Saima
    Chen, Christopher P.
    Lai, Mitchell K. P.
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 91 (03) : 989 - 998
12345